establishes that the appropriate INTELLECTUAL property provisions will be incorporated into agreements in light of existing hospital obligations and the likelihood that an invention will be included in the proposed work. As a non-profit organization, Partners HealthCare is committed to supporting patient care, research, teaching and community service by innovating throughout our system. Founded by Brigham and Women`s Hospital and Massachusetts General Hospital, Partners HealthCare supports a comprehensive continuum of care, including community and specialized hospitals, a management care organization, a physician network, municipal health centers, home care and other health services. Many of our hospitals teach employees at Harvard Medical School, and our system is a national leader in biomedical research. We focus on a people culture first for the patients in our system and our professional family. That`s why we offer our employees more opportunities to exploit their potential. Partner HealthCare strives to balance the personal goals of our employees with projects that match their skills and to create a culture that will enable our managers to become trusted mentors. We help every member of our team have their own personal development – and we recognize success at every step. Our employees use Partners HealthCare`s values to control decisions, actions and behaviours. These values guide how we do our work: patients, accessibility, responsibility, commitment to service, determination, innovation – thought risk; and how we deal with each other: Diversity – Inclusion, Integrity – Respect, Learning, Continuous Improvement – Personal Growth, Teamwork – Collaboration.The Clinical Research Agreement Associate I works under the direction of the Director of Industrial Sponsor Agreements and Relations at the Partners Clinical Trials Office (CTO) at the PHS Office of Chief Academic Officer. The Clinical Research Agreement Associate I collaborates with researchers, clinical trial coordinators, representatives of HealthCare System (PHS) partners (BWH, MGH, Spaulding, McLean, Newton-Wellesley and Dana Farber/Partners Cancer Care) as well as industry sponsors and contract research organizations to negotiate and implement clinical research agreements in accordance with PHS and institutional guidelines. Main tasks and responsibilities: check the IP questionnaire to determine if there are provisions contrary to CTO`s policy, including the code of conduct and conflict of interest guidelines, and, if so, negotiate acceptable terms.
Assess any risks to PHS that may be associated with unusual provisions of the agreement. The Clinical Research Agreement Associate I works under the close control of the Director, Corporate Sponsored Clinical Research Contracting and under the General Direction of the Corporate Director of the Office of Clinical Trials (CTO) within the PHS Office of the Chief Academic Officer. The Clinical Research Agreement Associate I collaborates with researchers, clinical trial coordinators, representatives of HealthCare System (PHS) partners (BWH, MGH, Spaulding, McLean, Newton-Wellesley and Dana Farber/Partners Cancer Care) as well as industry sponsors and contract research organizations to negotiate and implement clinical research agreements in accordance with PHS and institutional guidelines. Facilitate interactions with CTOs, Research Management Groups (RMs) and innovation groups regarding issues and agreements that overlap with CTO expertise, track the status of any ongoing contract negotiations through the departmental database. Prepares agreements for submission to sponsors using the standard CTO format for clinical research agreements. negotiates with the promoter, if necessary, in accordance with established guidelines, including provisions relating to publication rights, confidentiality, intellectual property rights, HIPAA, compensation and infringement of the object. Determines whether CTOs and sponsoring companies have negotiated a standard agreement for clinical trials and whether it applies to the proposed clinical trial.